← Open Payments lookup

SARA GARMON: Open Payments

NPI 1336801406 · SANTA FE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,494 in 144 payments from 38 companies in 2025. Trend: 2023 $2,936 · 2024 $3,279 · 2025 $3,494

Food & beverage: $2,596Long term medical supply or device loan: $798Education: $100
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation32$1,201
AstraZeneca Pharmaceuticals LP11$196
Janssen Biotech, Inc.9$183
SOBI, INC4$175
Celgene Corporation16$167
Exelixis Inc.7$151
ABBVIE INC.5$139
Incyte Corporation4$92
E.R. Squibb & Sons, L.L.C.5$85
Merck Sharp & Dohme LLC4$80

Products named: KISQALI, CABOMETYX, REBLOZYL, PLUVICTO, ENHERTU, VENCLEXTA, KEYTRUDA, FRUZAQLA.

Industry payments across NM — which companies pay providers there.